Sun Shaohua. Regulation of B-cell lymphoma/leukemia 11A on fetal hemoglobin. [J]. Journal of Chongqing Medical University 46(10):1281-1286(2021)
DOI:
Sun Shaohua. Regulation of B-cell lymphoma/leukemia 11A on fetal hemoglobin. [J]. Journal of Chongqing Medical University 46(10):1281-1286(2021) DOI: 10.13406/j.cnki.cyxb.002492.
Regulation of B-cell lymphoma/leukemia 11A on fetal hemoglobin
β-thalassemia and sickle cell anemia (SCA) are hemoglobin diseases caused by abnormal β-globin
occurring in South-east Asia
South Asia
North Africa and the Mediterranean region with different degrees. Elevated fetal hemoglobin (HbF) levels can significantly improve their clinical symptoms. B-cell lymphoma/leukemia 11A (BCL11A)
a zinc finger structure transcription factor
plays an important negative regulatory role in fetal-to-adult hemoglobin expression. Down-regulated BCL11A activates γ-globin
so as to increase fetal hemoglobin expression
alleviating clinical symptoms of β-thalassemia and SCA. This article focuses on the mechanism of BCL11A on γ-globin
and the treatment of β-thalassemia and SCA based on BCL11A
thereby providing a theoretical basis for the study of β-globin disease.